Exploring the possibility of sexual-behavioural primary prevention interventions for cervical cancer

Australian and New Zealand Journal of Public Health

Volumn 22, Issue 3, 1998, Pages 353-359

  Braun, Virginia ^a,b   Gavey, Nicola ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; FEMALE; HEALTH EDUCATION; HUMAN; NEW ZEALAND; PRIMARY PREVENTION; SEXUAL BEHAVIOR; SEXUAL EDUCATION; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER;

EID: 0031779452     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-842X.1998.tb01391.x     Document Type: Article

References (85)

1. Cox JT. Epidemiology of cervical intraepithelial neoplasia: The role of human papillomavirus. Bailliere's Clin Obstet Gynaecol 1995; 9: 1-37.
2. Schiffman MH, Brinton LA, The epidemiology of cervical carcinogenesis. Cancer 1995, 76. 1888-901.
3. Franco EL. Viral etiology of cervical cancer: A critique of the evidence. Reviews of Infectious Diseases 1991; 13: 1195-206.
4. Wilson S, Woodman C. Assessing the effectiveness of cervical screening. Clin Obstet Gynecol 1995; 38: 577-84.
5. Mitchell H. Epidemiology of cervical cancer and screening Cancer Forum 1990; 14: 143-5.
6. Beral V, Hermon C, Muñoz N, Devesa SS Cervical cancer. Cancer Surv 1994; 19: 265-85.
7. Day NE. The epidemiological basis for evaluating different screening policies. IARC Sci Publ 1986; 76: 199-209.
8. Howard J. 'Avoidable mortality' from cervical cancer Exploring the concept Soc Sci Med 1987; 24: 507-14.
9. Anderson GH, Boyes DA. Benedet JL, et al. Organisation and results of the cervical cytology screening programmmes in British Columbia, 1955-85. Br Med J 1988; 296: 975-8.
10. Garland SM, Faulkner-Jones BE, Fortune DW, Quinn MA Cervical cancer - what role for human papillomavirus? Med J Aust 1992, 156. 204-12.
11. Laara F., Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: Association with organised screening programmes. Lancet 1987; 1- 1247-9.
12. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engt J Med 1992; 327. 1272-8.
13. Tornatis L, Aitio A, Day NE, et al. IARC Sci Publ 1990; (100) 72-73, 276-9.
14. Braveman PA, Tarimo E Screening in primary health care Setting priorities with limited resources. Geneva: World Health Organisation, 1994.
15. Grimes DA, Economy KE. Primary prevention of gynecologic cancers. Am J Obstet Gynecol 1995; 172:227-35.
16. Grant NIR. Primary prevention. In: Lewis M, editor. Child and adolescent psychiatry: A comprehensive textbook. Baltimore (MA): Williams & Wilkins, 1991: 918-29.
17. Mahon SM Prevention and early detection of cancer in women. Semin Oncol Nurs 1995. 11: 88-102.
18. Cox B, Skegg DCG. Projections of cervical cancer mortality and incidence in New Zealand: The possible impact of screening. J Epidemiol Community Health 1992, 46: 373-7
19. Posner T, Vessey M Prevention of Cervical Cancer: The patient's view. London: King Edward's Hospital Fund in London, 1988.
20. Wardle J, Pernet A, Stephens D. Psychological consequences of positive results in cervical cancer screening. Psychology and Health 1995; 10: 185-94.
21. Kardinal CG. Cancer a potentially preventable disease. J La State Med Soc 1995; 147: 147-4.
22. Miller AB. Screening for cancer. West J Med 1988; 149: 718-22
23. Muñoz N, Bosch FX, de Sanjosé S, et al. The causal link between human papillomaviruses and invasive cervical cancer; A population-based case-control study in Colombia and Spain. Int J Cancer 1992; 52: 743-9.
24. zur Hausen H. Papillomaviruses in anogenital cancers as a model to understand the role of viruses in human cancers. Cancer Res 1989; 49: 4677-81
25. Fisher M, Rosenfeld WD, Burk RD. Cervicovaginal human papillomavirus infection in suburban adolescents and young adults. J Pediatr 1991, 119: 821-5.
26. Ley C, Bauer HM, Reingold A, et al. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 1991; 83: 997-1003.
27. Meekin GE, Sparrow MJ, Fenwicke RJ, Tobias M. Prevalence of genital human papillomavirus infection in Wellington women. Genitourin Med 1992, 68: 228-32.
28. Vail-Smith K, White DM, Risk level, knowledge and preventative behavior for human papillomaviruses among sexually active college women J Am Coll Health 1992, 40 227-30.
29. Muñoz N, Bosch FX, de Sanjose S, Shah KV. The rote of HPV on the etiology of cervical cancer Mutat Res 1994; 305: 293-301.
30. Bornstein J, Rahat MA, Abramovici H. Etiology of cervical cancer: Current concepts. Obstet Gvnecol Surv 1995. 50: 146-54.
31. Brinton LA. Epidemiology of cervical cancer - overview. IARC Sci Publ 1992; 119: 3-23.
32. Kjær SK, van den Brule AJC, Bock JE, et al. Human papillomavirus - the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 1996; 65: 601-6.
33. Winkelstein W Jr. Smoking and cervical cancer - current status: A review. Am J Epidemiol 1990, 131: 945-57.
34. Thomas DB, Ray RM. Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix The World Health Organisation collaborative study of neoplasia and steroid contraceptives. Am J Epidermiol 1996; 144 281-9.
35. Zondervan KT, Vessey MP Invasive cervical cancer and oral contraception. Gynaecology Forum 1996, 1: 16-9.
36. Burkett BJ, Peterson CM, Birch LM, et al. The relationship between contraceptives, sexual practices, and human papillomavirus infection among a college population. J Clin Epidemiol 1992, 45: 1295-302.
37. Celentano DD, Klassen AC, Weisman CS, Rosenshein NB. The role of contraceptive use in cervical cancer: The Maryland cervical cancer case-control study. AmJ Epidemiol 1987; 126: 594-604
38. Kjær SK, Jensen OM. Comparison studies of HPV detection in areas at different risk for cervical cancer IARC Sci Publ 1992; 119: 243-9
39. Peters RK, Thomas D. Hagan DG, et al. Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles county J Natl Cancer Inst 1986; 77: 1063-77.
40. Slattery ML, Overall JC, Abbott TM, et al. Sexual activity, contraception, genital infections, and cervical cancer: Support for the sexually transmitted disease hypothesis. Am J Epidemiol 1989; 130: 248-58
41. Zondervan KT, Carpenter LM, Painter R, Vessey MP. Oral contraceptives and cervical cancer - further findings from the Oxford Family Planning Association contraception study. Br J Cancer 1996, 73: 1291-7
42. Butterworth CE, Hatch KE. Macaluso M, et al. Folate deficiency and cervical dysplasia. J Am Med Assoc 1992; 267: 528-33.
43. Fairley CK, Chen S, Tabrizi SN, et al. The absence of genital human papillomavirus DNA in virginal women, Int J STD AIDS 1992; 3: 414-7.
44. Bosch FX, Manos MM, Muñoz N, et al. Prevalence of human papillomavirus in cervical cancer A worldwide perspective. J Natl Cancer Inst 1995; 87: 796-802.
45. McNeil C. Cervical cancer: Following the HPV pathway [news]. J Natl Cancer Inst 1995, 87: 1354-5.
46. Braun. V. Cervical Cancer Prevention Policy in New Zealand: Past influences, future directions, and discursive formulations [thesis, unpublished]. Auckland: The University of Auckland, 1997.
47. A WHO Meeting. Control of cancer of cervix uteri. Bull World Health Organ 1986; 64: 607-18.
48. Skegg DCG, Corwin PA, Paul C, Doll, R. Importance of the male factor in cancer of the cervix. Lancet 1982; 2: 581-3.
49. Doyal L What makes women sick? Gender and the political economy of health. London: Macmillan, 1995.
50. Graham CA. Cervix cancer prevention and detection update. Semin Oncol Nurs 1993, 9: 155-62.
51. Franceschi S. Ovarian and endometrial cancer. Benefits of oral contraception. Gvnaecology Forum 1996; 1- 10-3.
52. Eardley A, Elkind AK, Spencer B. et al. Attendance for cervical screening - whose problem? Soc Sci Med 1985; 20: 955-62.
53. McNeil C. Consensus panel of cervical cancer highlights the HPV connection [news]. J Natl Cancer Inst 1996; 88: 575.
54. Barro AR. Women and cancer: The impact and feasibility of practicing prevention. Health Values 1986; 10: 5-15.
55. Birley HDL. Human papillomaviruses, cervical cancer and the Developing World. Ann Trop Med Parasitol 1995, 89: 453-63.
56. Davey B. Cervical cancer: Connections and causes. Nursing Times 1986; 82: 33-4.
57. Kenney JW. Reuss H Human papillomavirus as expressed in cervical neoplasia. Evolving diagnostic and treatment modalities. Health Care for Women International 1994; 15: 287-96.
58. Ministry of Health/Manatu Hauora. Sexually transmitted diseases: Prevention and control: The public health issues 1996-1997. Wellington (NZ): Ministry of Health, 1997.
59. Public Health Commission/Rangapu Hauora Tumatanui Cervical cancer: The Public Health Commission 's Advice to the Minister of Health. Wellington (NZ): Public Health Commission, 1994.
60. Department of Health/Te Tari Ora. Promoting cervical screening: Information for health workers. Wellington (NZ): Department of Health. 1990: 16:
61. National Cervical Screening Programme. Policy Statement of the National Cervical Screening Programme Expert Group. Wellington (NZ): National Cervical Screening Programme Expert Group, 1990
62. Ministry of Health/Manatu Hauora. National Cervical Screening Programme Policy. Wellington (NZ): Ministry of Health, 1996
63. Barnhard KT, Sondheimer SJ. Contraception choice and sexually transmitted disease. Curr Opin Obstet Gvnecol 1993; 5: 823-8.
64. Braverman PK, Strasburger VC. Sexually transmitted diseases. Clin Pediatr 1994; 33: 26-37.
65. Gneco A. Cutting the risks for STDs. Medical Aspects of Human Sexuality 1987, 21: 70-84
66. Marot, F. Teenagers and sex: A suitable case for education. Prof Care Mother Child 1994; 4(2): 46-9
67. Hildesheim A, Brinton LA, Mallin K. et al. Bamer and spermicidal contraceptive methods and risk of invasive cervical cancer. Epidemiology 1990; 1: 266-72.
68. Sarafino EP. Health psychology: Biopsychosocial interactions. 2nd ed. New York: Wiley, 1994.
69. Gotay CC Why me? Attributions and adjustment by cancer patients and their mates at two stages in the disease process. Soc Sci Med 1985; 20: 825-31.
70. Sachs L. Causality, responsibility and blame - core issues in the ultural construction and subtext of prevention. Social Health Illn 1996; 18: 632-52.
71. Howson, 1993, cited in McKie L Women hearing men: The cervical smear test and the social construction of sexuality. In: Holland J, Adkins L, editors Sex, sensibility and the gendered body. London: Macmillan Press. 1996: 120-35.
72. Alonzo AA, Reynolds NR Stigma, HIV and AIDS - an exploration and elaboration of a stigma trajectory Soc Sci Med 1995; 41: 303-15.
73. Conrad P, Kern R The social and cultural meanings of illness. In: Conrad P, Kern R, editors. The sociology of health and illness: Critical perspectives. 3rd edition New York: St. Martin's Press, 1990; 266-9
74. Gilmore N, Somerville MA. Stigmatization. scapegoating and discrimination in sexually transmitted diseases: Overcoming 'them' and 'us'. Soc Sci Med 1994; 39: 1339-58.
75. Crandall CS, Moriarty D. Physical illness stigma and social rejection. Br J Soc Psychol 1995; 34: 67-83.
76. Nettleton S. The sociology of health and illness. Cambridge: Polity Press, 1995.
77. Patton C. Resistance and the erotic In: Aggleton P, Hart G, Davies P, editors. AIDS: Social representations, social practices. New York: The Falmer Press, 1989: 237-63.
78. White GE. Older women's attitudes to cervical screening and cervical cancer: A New Zealand experience. J Adv Nurs 1995; 21: 659-66.
79. Moore L. Teens decry poor sex schooling. New Zealand Herald 26 September 1996; Sect A: 11.
80. Keller ML, Egan JJ, Mims LF Genital human papillomavirus infection: Common but not trivial Health Care Women Int 1995; 16: 351-64.
81. Johnson K. Screening for human papillomavirus infection. In: Canadian Taskforce on the Periodic Health Exam, editor. The Canadian Guide to Clinical Preventive Health Care Ottawa: Health Canada. 1994; 768-76
82. Koutsky LA., Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection Epidemiol Rev 1988, 10 122-63.
83. Lyttle H, Preston J. Sexually transmitted diseases and activities in New Zealand STD/sexual health clinics, 1994. Venereology 1996, 9: 193-5.
84. Stoker L. Falling in love with condoms. Healthright 1990; 9: 35-7.
85. Syrjanen K, Yliskoski M, Kataja V, et al Prevalence of genital human papillomavirus infections in a mass-screened Finnish female population aged 20-65 years, Int J Std Aids 1990: 1: 410-5.